The Role of AQP5 in Chronic Myelogenous Leukemia
Author Information
Author(s): Chae Young Kwang, Kang Sung Koo, Kim Myoung Sook, Woo Janghee, Lee Juna, Chang Steven, Kim Dong-Wook, Kim Myungshin, Park Seonyang, Kim Inho, Keam Bhumsuk, Rhee Jiyoung, Koo Nam Hee, Park Gyeongsin, Kim Soo-Hyun, Jang Se-Eun, Kweon Il-Young, Sidransky David, Moon Chulso
Primary Institution: Johns Hopkins University
Hypothesis
AQP5 may trigger cell proliferation in leukemic cells.
Conclusion
AQP5 is overexpressed in CML cells and promotes cell proliferation while inhibiting apoptosis.
Supporting Evidence
- AQP5 expression was found in 32% of CML patient samples.
- Overexpression of AQP5 in K562 cells increased cell proliferation.
- siRNA targeting AQP5 reduced cell proliferation in CML cells.
- AQP5 expression increased with imatinib mesylate resistance.
- Immunohistochemistry showed AQP5 expression in CML cells but not in normal bone marrow.
Takeaway
AQP5 is a protein that helps CML cells grow and survive, which could be important for new treatments.
Methodology
The study involved RT-PCR, immunohistochemistry, and cell proliferation assays to analyze AQP5 expression in CML cells.
Limitations
The study did not find genomic amplification of AQP5, suggesting other mechanisms may regulate its expression.
Participant Demographics
41 CML patients and 5 normal bone marrow donors.
Statistical Information
P-Value
0.047
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website